Flex Pharma, Inc. (NASDAQ:FLKS) Posts Basic Consolidated EPS Of $-2.0767

0

Flex Pharma, Inc. (NASDAQ:FLKS)managed to report annual basic consolidated EPS of $-2.0767, which was for the year ended2015-12-31.The company reported basic consolidated EPS of $-2.0767 for the quarter ended 2015-12-31.

EPS from continuing operations

If you look at the performance of the company’s continuing operations, you see that EPS generated from such operations was {EPS_BASIC_CONT_OPER:1541}} for the year ended 2015-12-31. As for the quarter ended 2015-12-31, continuing operations produced EPS of $-0.7055.

EPS contribution from parent

Flex Pharma, Inc. (NASDAQ:FLKS) received of $-2.0767 EPS boost from the parent company for the annual period ended

For the year ended 2015-12-31, the parent of Flex Pharma, Inc. (NASDAQ:FLKS) contributed EPS of $-2.0767 to the company’s bottom-line. But for the quarter ended 2015-12-31, EPS boost from the parent was cited as $-2.0767.

What About Basic net EPS

The basic net EPS that Flex Pharma, Inc. (NASDAQ:FLKS) reported for the year ended 2015-12-31 stood at $-2.08. For the quarter ended 2015-12-31, the company posted basic net EPS of $-2.08.

What About Consolidated Diluted EPS?

Flex Pharma, Inc. (NASDAQ:FLKS)’s consolidated diluted EPS for the year ended 2015-12-31 was reported as $-2.0767. For the quarter ended 2015-12-31 the metric was$-2.0767.

Basic diluted EPS

The company managed to register diluted EPS from continuing operation of at $-2.0767 for the yearended 2015-12-31. But diluted EPS from continuing operations for the quarter ended 2015-12-31 came in at $-2.0767.

Net diluted EPS

Net diluted EPS posted by Flex Pharma, Inc. (NASDAQ:FLKS) for the year ended 2015-12-31 was $-2.08. On quarterly basis, net diluted EPS for the quarter ended 2015-12-31 was reported as $-2.08.

What portion of diluted EPS came from parent?

For the annual period ended 2015-12-31, the parent company of Flex Pharma, Inc. (NASDAQ:FLKS) said that it parent company boosted its diluted EPS by$-2.0767 in the year ended 2015-12-31. For the quarter ended 2015-12-31, the parent company’s contribution to diluted EPS was $-2.0767.

The company reported net basic EPS of $-2.08 for the year ended 2015-12-31 and net basic EPS of $-2.08 for the quarter ended 2015-12-31.

The number of Flex Pharma, Inc. (NASDAQ:FLKS)’s basic shares outstanding at the end of the annual period ended 2015-12-31 was 14.033. That compares with 14.033 basic shares outstanding for the quarter ended 2015-12-31.

Flex Pharma, Inc. (NASDAQ:FLKS) had 14.033 diluted shares outstanding at the end of the annual period ended 2015-12-31. But for the quarter ended 2015-12-31, diluted outstanding shares were 14.033.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 22 times, 1 visits today)